REFERENCES
- Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage. 2004;28(5):497–504.
- Ito K, Kubota Y, Toda T, Suto S, Ikarashi N, Sugiyama K. Effect of hydrocotarnine on cytochrome P450 and P-glycoprotein. Drug Metab Pharmacokinet. 2009;24(1):108–113.
- Estimated World Requirements for 2011 - Statistics for 2009, Part four. Statistical information on narcotic drugs. Available at http://www.incb.org/pdf/technical-reports/narcotic-drugs/2010/NAR_2010_EFS_Part4.pdf Accessed Oct 12, 2011.
- Kokubun H, Ouki M, Matoba M, Kubo H, Hoka S, Yago K. Determination of oxycodone and hydrocotarnine in cancer patient serum by high-performance liquid chromatography with electrochemical detection. Anal Sci. 2005;21(3):337–339.
- Sheiner L B, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm. 1977;5(5):445–479.
- Ette EI. Stability and performance of a population pharmacokinetic model. J Clin Pharmacol. 1997;37(6):486–495.
- Tallgren M, Olkkola KT, Seppälä T, Hockerstedt K, Lindgren L. Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantati. Clin Pharmacol Ther. 1997;61(6): 655–661.
- Kaiko RF. Pharmacokinetics and pharmacodynamics of controlled-release opioids. Acta Anaesthesiol Scand. 1997;41 (1 Pt 2):166–174.
- Nakamura K, Kokubun H, Komatsu T, Matoba M, Hoka S, Yago K. Pharmacokinetics of controlled-release oxycodone in patients with cancer pain. Gan To Kagaku Ryoho. 2007;34(9): 1449–1453.
- Mandema JW, Kaiko RF, Oshlack B, Reder RF, Stanski DR. Characterization and validation of a pharmacokinetic model for controlled-release oxycodone. Br J Clin Pharmacol. 1996;42(6): 747–756.
- Sunshine A, Olson NZ, Colon A, Rievera J, Kaiko RF, Fitzmartin RD, Analgesic efficacy of controlled-release oxycodone in postoperative pain. J Clin Pharmacol. 1996;36(7): 595–603.
- Poyhia R, Seppala T, Olkkola KT, Kalso E. The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects. Br J Clin Pharmacol. 1992;33(6):617–621
- Leow KP, Smith MT, Williams B, Gramond T. Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer. Clin Pharmacol Ther. 1992;52(5):487–495.
- Kokki M, Välitalo P, Rasanen I, Aaltomaa S, Ojanperä I, Eskelinen M, Kokki H. Absorption of different oral dosage forms of oxycodone in the elderly: a cross-over clinical trial in patients undergoing cystoscopy. Eur J Clin Pharmacol. 2012 Mar 27: [Epub ahead of print.